The Role of p53 in Metabolic Regulation
Open accessThe DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Abstract
The metabolic changes that occur in a cancer cell have been studied for a few decades, but our appreciation of the complexity and importance of those changes is now being realized. The metabolic switch from oxidative phosphorylation to aerobic glycolysis provides intermediates for cell growth and division and is regulated by both oncogenes and tumor suppressor genes. The p53 tumor suppressor gene has long been shown to play key roles in responding to DNA damage, hypoxia, and oncogenic activation. However, now p53 has added the ability to mediate metabolic changes in cells through the regulation of energy metabolism and oxidative stress to its repertoire of activities. It is therefore the focus of this review to discuss the metabolic pathways regulated by p53 and their cooperation in controlling cancer cell metabolism.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In addition to stopping senescent cell proliferation, p53 and RB mediate senescence-related metabolic changes by balancing their effects on glycolysis: p53 restricts the glycolysis activity of senescent cells through several mechanisms [226], while RB upregulates glycolytic genes, resulting in high glycolytic activity [227].”
From Mechanisms and Regulation of Cellular Senescence (2021) · cites this paper as [226]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Ide, T., Brown-Endres, L., Chu, K., Ongusaha, P. P., Ohtsuka, T., El-Deiry, W. S., Aaronson, S. A., & Lee, S. W. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.09.031 · Cited by 92
RetractedOxidative stress, inflammation, and cancer: How are they linked?
Reuter, S., Gupta, S. C., Chaturvedi, M. M., & Aggarwal, B. B. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.09.006 · Cited by 5,441 · cited 1×
“, superoxide dismutase [SOD], glutathione peroxidase [GPx], and GSH) through protective mechanisms.(39) Even though ROS products are part of normal cellular metabolism produced mainly through the mitochondrial respiratory chain and play roles in cell proliferation and survival signaling Figure 2.”
BackgroundThe Biology of Cancer: Metabolic Reprogramming Fuels Cell Growth and Proliferation
DeBerardinis, R. J., Lum, J. J., Hatzivassiliou, G., & Thompson, C. B. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.10.002 · Cited by 4,088 · cited 2×
“In cancer cells, AKT activation is also sufficient to drive glycolysis and lactate production and to suppress macromolecular degradation.(31) AMPK is a heterotrimeric protein consisting of 3 subunits—α, β, and γ—and drives the catabolic, energyproducing responses (i.”
BackgroundOn Respiratory Impairment in Cancer Cells
Warburg, O. (1956) · Science · doi:10.1126/science.124.3215.269 · Cited by 3,468
The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth
Christofk, H. R., Vander Heiden, M. G., Harris, M. H., Ramanathan, A., Gerszten, R. E., Wei, R., Fleming, M. D., Schreiber, S. L., & Cantley, L. C. (2008) · Nature · doi:10.1038/nature06734 · Cited by 2,820 · cited 1×
“Pyruvate kinase–M2 (PK-M2) is the embryonic splice variant of the rate-limiting enzyme for pyruvate generation that is preferentially expressed in tumor cells and regulates the flux of carbon into ribose-5-phosphate and nucleotide synthesis via phosphotyrosine signaling.(5) Since PK-M2 can regulate the amounts of pyru…”
BackgroundA model for p53-induced apoptosis
Polyak, K., Xia, Y., Zweier, J. L., Kinzler, K. W., & Vogelstein, B. (1997) · Nature · doi:10.1038/38525 · Cited by 2,500
TIGAR, a p53-Inducible Regulator of Glycolysis and Apoptosis
Bensaad, K., Tsuruta, A., Selak, M. A., Vidal, M. N. C., Nakano, K., Bartrons, R., Gottlieb, E., & Vousden, K. H. (2006) · Cell · doi:10.1016/j.cell.2006.05.036 · Cited by 2,019 · cited 1×
“The p53 protein induces the transcription of the TIGAR gene, which lowers the intracellular concentrations of fructose-2,6-bisphosphate and thus decreases glycolysis and overall levels of intracellular reactive oxygen species (ROS).(8) The decrease in glycolysis allows for entry into the pentose phosphate pathway (PPP…”
Backgroundp53 Has a Direct Apoptogenic Role at the Mitochondria
Mihara, M., Erster, S., Zaika, A., Petrenko, O., Chittenden, T., Pancoska, P., & Moll, U. M. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00050-9 · Cited by 1,777 · cited 1×
“In contrast to the above target gene regulation, p53 can form a complex with the antiapoptotic proteins BCL-X L and PUMA, resulting in cytochrome c release from mitochondria and promotion of mitochondrial outer membrane permeabilization.(14) p53’s role in the regulation of cellular metabolism is complex given the many…”
Backgroundp53 Regulates Mitochondrial Respiration
Matoba, S., Kang, J.-G., Patino, W. D., Wragg, A., Boehm, M., Gavrilova, O., Hurley, P. J., Bunz, F., & Hwang, P. M. (2006) · Science · doi:10.1126/science.1126863 · Cited by 1,650 · cited 2×
“One way p53 balances the usage of the respiratory and glycolytic pathways is through its downstream mediator, SCO2.(13) SCO2 is critical for regulating a major site of oxygen utilization in the cell, the cytochrome c oxidase (COX) complex.”
BackgroundBrugarolas, J., Lei, K., Hurley, R. L., Manning, B. D., Reiling, J. H., Hafen, E., Witters, L. A., Ellisen, L. W., & Kaelin, W. G. (2004) · Genes & Development · doi:10.1101/gad.1256804 · Cited by 1,384 · cited 1×
“REDD1 overexpression can also downregulate S6K phosphorylation in a TSC1/ TSC2-dependent manner.(33,37) Thus, p53 shuts down IGF-1/AKT and mTOR pathways through the negative regulation of IGF-BP3, PTEN, TSC2, AMPK β1, and sestrins 1 and 2 and thus plays a critical role in cell growth and division, nutritional sensing,…”
Background
Cited by
The Tumor Suppressor p53 Limits Ferroptosis by Blocking DPP4 Activity
Xie, Y., Zhu, S., Song, X., Sun, X., Fan, Y., Liu, J., Zhong, M., Yuan, H., Zhang, L., Billiar, T. R., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.07.055 · Cited by 952
“TP53-mediated metabolic changes that occur in cancer cells have been studied for several decades, but our appreciation of the complexity and importance of those changes is only now being realized (Humpton and Vousden, 2016; Parrales and Iwakuma, 2016; Puzio-Kuter, 2011; Vousden and Ryan, 2009).”
PGC-1 α, Inflammation, and Oxidative Stress: An Integrative View in Metabolism
Rius-Pérez, S., Torres-Cuevas, I., Millán, I., Ortega, Á. L., & Pérez, S. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/1452696 · Cited by 642
“On the other hand, p53 may be repressed transcriptionally by GLUT-1 and GLUT-4 genes in situations such as excess caloric intake that cause reduction of PGC-1α, NRF-1, and Tfam activation [123, 124].”
BackgroundRoberts, D. J., & Miyamoto, S. (2015) · Cell Death & Differentiation · doi:10.1038/cdd.2014.173 · Cited by 504
Mitochondrial Sirtuin 3: New emerging biological function and therapeutic target
Zhang, J., Xiang, H., Liu, J., Chen, Y., He, R.-R., & Liu, B. (2020) · Theranostics · doi:10.7150/thno.45922 · Cited by 503
“The stabilization of p53 further impedes glycolysis via inhibition of the transcription of numerous key glycolytic enzymes [87].”
BackgroundFrom Ancient Pathways to Aging Cells—Connecting Metabolism and Cellular Senescence
Wiley, C. D., & Campisi, J. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.05.010 · Cited by 440
“Beyond establishing the proliferative arrest of senescent cells, p53 also plays an important role in the regulation of glycolysis (Kruiswijk et al., 2015; Puzio-Kuter, 2011).”
BackgroundMechanisms and Regulation of Cellular Senescence
Roger, L., Tomas, F., & Gire, V. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222313173 · Cited by 395
“In addition to stopping senescent cell proliferation, p53 and RB mediate senescencerelated metabolic changes by balancing their effects on glycolysis: p53 restricts the glycolysis activity of senescent cells through several mechanisms [226], while RB upregulates glycolytic genes, resulting in high glycolytic activity…”
BackgroundCancer metabolism: current perspectives and future directions
Muñoz-Pinedo, C., El Mjiyad, N., & Ricci, J.-E. (2012) · Cell Death & Disease · doi:10.1038/cddis.2011.123 · Cited by 385
Targeting cell cycle regulation in cancer therapy
Diaz-Moralli, S., Tarrado-Castellarnau, M., Miranda, A., & Cascante, M. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.01.011 · Cited by 361
Metabolic Codependencies in the Tumor Microenvironment
Dey, P., Kimmelman, A. C., & DePinho, R. A. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-1211 · Cited by 328
APR-246 reactivates mutant p53 by targeting cysteines 124 and 277
Zhang, Q., Bykov, V. J. N., Wiman, K. G., & Zawacka-Pankau, J. (2018) · Cell Death & Disease · doi:10.1038/s41419-018-0463-7 · Cited by 261
A systematic review of p53 regulation of oxidative stress in skeletal muscle
Beyfuss, K., & Hood, D. A. (2018) · Redox Report · doi:10.1080/13510002.2017.1416773 · Cited by 239
“Furthermore, p53 can regulate glycolysis by reducing glycolytic energy production and enhancing the pentose phosphate, fatty acid oxidation, and oxidative phosphorylation energy pathways [26,36,37,42,52].”
BackgroundInfluentialEisenreich, W., Rudel, T., Heesemann, J., & Goebel, W. (2019) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2019.00042 · Cited by 220
“Tumor suppressors, such as p53, the phosphatase and tensin homolog (PTEN), the retinoblastoma protein (RB), sirtuins (SIRT)-3 and−6, as well as the liver kinase B1/AMP-activated protein kinase (LKB1/AMPK), which act at various metabolic key nodes (Shackelford and Shaw, 2009; Puzio-Kuter, 2011; Houtkooper et al., 2012;…”
BackgroundMutant p53 Gain-of-Function: Role in Cancer Development, Progression, and Therapeutic Approaches
Alvarado-Ortiz, E., de la Cruz-López, K. G., Becerril-Rico, J., Sarabia-Sánchez, M. A., Ortiz-Sánchez, E., & García-Carrancá, A. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.607670 · Cited by 180
“Antioxidant defense mechanisms modulated by p53 include increasing levels of GST (glutathione S-transferase), an important enzyme implicated in avoiding the deleterious effects of ROS (reactive oxygen species) (Puzio-Kuter, 2011).”
BackgroundMetabolic Plasticity in Chemotherapy Resistance
Desbats, M. A., Giacomini, I., Prayer-Galetti, T., & Montopoli, M. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00281 · Cited by 183
“p53 can directly or indirectly influence the expression of genes involved in glucose, OxPhos and lipid metabolism, among other pathways (58).”
BackgroundThe role of the p53 tumor suppressor in metabolism and diabetes
Kung, C.-P., & Murphy, M. E. (2016) · Journal of Endocrinology · doi:10.1530/joe-16-0324 · Cited by 178
One-carbon metabolism and nucleotide biosynthesis as attractive targets for anticancer therapy
Shuvalov, O., Petukhov, A., Daks, A., Fedorova, O., Vasileva, E., & Barlev, N. A. (2017) · Oncotarget · doi:10.18632/oncotarget.15053 · Cited by 168
“Also, p53 was reported to increase glycolysis [96].”
BackgroundTargeting Metabolism in Cancer Cells and the Tumour Microenvironment for Cancer Therapy
Li, J., Eu, J. Q., Kong, L. R., Wang, L., Lim, Y. C., Goh, B. C., & Wong, A. L. A. (2020) · Molecules · doi:10.3390/molecules25204831 · Cited by 159
“Loss of p53 triggers OXPHOS [45], and certain tumours are known to retain wild-type p53 to maintain glycolysis, such as in hepatocellular carcinoma (HCC) [46].”
BackgroundKhan, H. Z., Reale, M., Ullah, H., Sureda, A., Tejada, S., Wang, Y., Zhang, Z., & Xiao, J. (2019) · Biotechnology Advances · doi:10.1016/j.biotechadv.2019.04.007 · Cited by 168
Ferredoxin reductase is critical for p53-dependent tumor suppression via iron regulatory protein 2
Zhang, Y., Qian, Y., Zhang, J., Yan, W., Jung, Y.-S., Chen, M., Huang, E., Lloyd, K., Duan, Y., Wang, J., et al. (2017) · Genes & Development · doi:10.1101/gad.299388.117 · Cited by 151
Mitochondria and Cancer: A Growing Role in Apoptosis, Cancer Cell Metabolism and Dedifferentiation
Scatena, R. (2011) · Advances in experimental medicine and biology · doi:10.1007/978-94-007-2869-1_13 · Cited by 163
“These results demonstrated that GLS2 is a mediator of p53 ¢ s role in energy metabolism and antioxidant defence, and this likely contributes to its role in tumour suppression (Puzio-Kuter 2011 ) .”
BackgroundXiong, Y., Sun, J., & Glass, N. L. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004500 · Cited by 147
“As VIB1 mediates metabolic changes as well as programmed death, two properties shared by mammalian tumor suppressor p53 [75,76], the molecular mechanism in linking the two could be conserved, and further investigation of vib-1 function and its homologs in filamentous fungi may also shed light on cancer research.”
BackgroundMutual regulation of metabolic processes and proinflammatory NF-κB signaling
Kracht, M., Müller‐Ladner, U., & Schmitz, M. L. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.07.027 · Cited by 141
Woolf, E. C., Syed, N., & Scheck, A. C. (2016) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2016.00122 · Cited by 123
“…pivotal role in the cellular responses to hypoxia, DNA damage and oncogene activation is now known to regulate glycolysis and assist in maintaining mitochondrial integrity (Olovnikov et al., 2009; Madan et al., 2011; Puzio-Kuter, 2011; Kim and Kim, 2013; Iurlaro et al., 2014; Barron et al., 2016).”
BackgroundPolicastro, L. L., Ibañez, I. L., Notcovich, C., Duran, H. A., & Podhajcer, O. L. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2011.4367 · Cited by 120
“The tumor suppressor p53 is also an important regulator of metabolism by inhibiting the glycolytic pathway through different mechanisms (39, 254).”
Fox, D. K., Ebert, S. M., Bongers, K. S., Dyle, M. C., Bullard, S. A., Dierdorff, J. M., Kunkel, S. D., & Adams, C. M. (2014) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00010.2014 · Cited by 117
“Like ATF4, p53 is a stress-induced transcription factor that mediates cellular adaptations to stress (27, 39, 47).”
BackgroundNutrient-sensing mTORC1: Integration of metabolic and autophagic signals
Tan, V. P., & Miyamoto, S. (2016) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2016.01.005 · Cited by 119
“In addition to the established role of p53 in cell death, it is becoming increasingly recognized that basal or low levels of p53 expression plays an important role in the maintenance of redox state as well as energy homeostasis [180-186].”
Crosstalk of lncRNA and Cellular Metabolism and Their Regulatory Mechanism in Cancer
Lin, Y.-H. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21082947 · Cited by 106
“The loss of p53 in the cell can lead to mitochondrial respiratory damage and increased glycolysis [85].”
BackgroundMethyl Jasmonate: Putative Mechanisms of Action on Cancer Cells Cycle, Metabolism, and Apoptosis
Cesari, I. M., Carvalho, É., Rodrigues, M. F., Mendonça, B. D. S., Amoêdo, N. D., & Rumjanek, F. D. (2014) · International Journal of Cell Biology · doi:10.1155/2014/572097 · Cited by 113
“In case ofmild cellular stress, low levels of p53 can activate the TP53-induced glycolysis and apoptosis regulator (TIGAR) gene that decreases the rate of glycolysis and hence ROS levels in the cell [64].”
BackgroundThe ketogenic diet for the treatment of malignant glioma
Woolf, E. C., & Scheck, A. C. (2014) · Journal of Lipid Research · doi:10.1194/jlr.r046797 · Cited by 102
Lee, P., Vousden, K. H., & Cheung, E. C. (2014) · Cancer & Metabolism · doi:10.1186/2049-3002-2-1 · Cited by 107
“There have been many reviews of the role of p53 in regulating metabolic pathways, reflecting the complex interplay between p53-mediated responses that promote cell survival and those that induce cell death [53].”
BackgroundDelineation of the Key Aspects in the Regulation of Epithelial Monolayer Formation
Aschauer, L., Gruber, L. N., Pfaller, W., Limonciel, A., Athersuch, T. J., Cavill, R., Khan, A., Gstraunthaler, G. J. A., Grillari, J., Grillari‐Voglauer, R., et al. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.01435-12 · Cited by 97
“This highlights the central role of p53 in epithelial maturation by promoting cell cycle arrest, oxidative phosphorylation, and suppression of glycolysis, as has been shown within different cellular contexts (57, 58).”
BackgroundTargeting Tumor Suppressor Networks for Cancer Therapeutics
Guo, X. E., Ngo, B., Modrek, A. S., & Lee, W. (2014) · Current Drug Targets · doi:10.2174/1389450114666140106095151 · Cited by 106
“Indeed, as p53 deficient cancer cells often undergo aerobic glycolysis (also known as the Warburg effect), additional p53 functions in regulating glycolysis and Reactive Oxygen Species (ROS) have been proposed to further contribute to the tumor suppression effect of p53 (59).”
BackgroundCell death in head and neck cancer pathogenesis and treatment
Raudenská, M., Balvan, J., & Masařík, M. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03474-5 · Cited by 87
Meng, X., Lu, Z., Lv, Q., Jiang, Y., Zhang, L., & Wang, Z. (2022) · Acta Biomaterialia · doi:10.1016/j.actbio.2022.04.022 · Cited by 87
The Role of Caspase-2 in Regulating Cell Fate
Vigneswara, V., & Ahmed, Z. (2020) · Cells · doi:10.3390/cells9051259 · Cited by 90
Glycolysis-mediated control of blood-brain barrier development and function
Salmina, A. B., Kuvacheva, N. V., Morgun, A. V., Komleva, Y. K., Пожиленкова, Е. А., Lopatina, O. L., Gorina, Y. V., Таранушенко, Т. Е., & Petrova, L. L. (2015) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2015.04.005 · Cited by 81
Deregulated transcription factors in cancer cell metabolisms and reprogramming
Kant, R., Manne, R., Anas, M., Penugurti, V., Chen, T., Pan, B., Hsu, C.-C., & Lin, H. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.10.001 · Cited by 81
Carbon Source Metabolism and Its Regulation in Cancer Cells
Yin, C., Qie, S., & Sang, N. (2012) · Critical Reviews in Eukaryotic Gene Expression · doi:10.1615/critreveukargeneexpr.v22.i1.20 · Cited by 75
Zhao, K., Zhou, Y., Qiao, C., Ni, T., Li, Z., Wang, X., Guo, Q., Lu, N., & Wei, L. (2015) · Journal of Hematology & Oncology · doi:10.1186/s13045-015-0137-1 · Cited by 69
“By regulating the levels of a series of gene products that affect metabolic fates and metabolic products, p53 helps to slow down glycolysis and promote oxidative phosphorylation [4].”
BackgroundDeterminants of nutrient limitation in cancer
Sullivan, M. R., & Heiden, M. G. V. (2019) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409238.2019.1611733 · Cited by 72
“…death (Jiang L et al. 2015). p53 can directly or indirectly influence expression of genes involved in lipid metabolism, amino acid transport and synthesis, and other metabolic pathways (Puzio-Kuter 2011), making it difficult to predict a priori exactly how nutrient demands are altered by p53 loss.”
BackgroundZhou, Y., Niu, W., Luo, Y., Li, H., Xie, Y., Wang, H., Liu, Y., Fan, S., Li, Z., Xiong, W., et al. (2019) · Cancer Science · doi:10.1111/cas.13928 · Cited by 66
Cruz‐Gregorio, A., Martínez-Ramírez, I., Pedraza‐Chaverrí, J., & Lizano, M. (2019) · Cancers · doi:10.3390/cancers11020182 · Cited by 71
“On the contrary, mutations found in HPV-negative HNSCC cases inactivate the function of tumour suppressors such as p53, favouring glycolysis; since when p53 is functionally active, it induces the inhibition of glycolysis mainly through the activation of the protein TP53-induced glycolysis and apoptosis regulator (TIGA…”
BackgroundZheng, Z., Wu, D., Fan, S., Zhang, Z.-F., Chen, G., & Lu, J. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.29182 · Cited by 69
“P53 regulates metabolic events and hence is also important in mitochondrial energy metabolism.(38) In addition, P53 has been reported to modulate glycolysis(38) and OXPHOS.”
BackgroundGiuliani, A., Prattichizzo, F., Micolucci, L., Ceriello, A., Procopio, A. D., & Rippo, M. R. (2017) · Mediators of Inflammation · doi:10.1155/2017/2309034 · Cited by 73
“AMPK activation, in turn, can induce senescence via p53 phosphorylation [41], whose activation has been associated with the promotion of glycolysis and oxidative phosphorylation, but even to downmodulation of glycolysis [42].”
BackgroundMitochondrial Retrograde Signalling and Metabolic Alterations in the Tumour Microenvironment
Yang, D., & Kim, J. (2019) · Cells · doi:10.3390/cells8030275 · Cited by 71
“p53 mediated suppression of HIF-1α controls regulation of glycolysis and ‘loss of function mutation’ of p53 is partially responsible for enhanced glycolysis in cancer cells [162].”
Eisenreich, W., Heesemann, J., Rudel, T., & Goebel, W. (2015) · Microbiology Spectrum · doi:10.1128/microbiolspec.mbp-0002-2014 · Cited by 76
“Common cellular regulators, including tumor suppressors and oncogenes, are involved in the orchestration of the entire cell metabolism (53 – 54).”
BackgroundMetabolic control of signalling pathways and metabolic auto‐regulation
Lorendeau, D., Christen, S., Rinaldi, G., & Fendt, S. (2015) · Biology of the Cell · doi:10.1111/boc.201500015 · Cited by 69
“Although we have extensive knowledge about the regulation p53 exhibits on cellular metabolism (Vousden and Ryan, 2009; Puzio-Kuter 2011; Berkers et al., 2013), there is also recent evidence for a feedback control from metabolism to p53 (Figure 2).”
BackgroundLeo, L. D., Vegliante, R., Ciccarone, F., Salvatori, I., Scimeca, M., Bonanno, E., Sagnotta, A., Grazi, G. L., Aquilano, K., & Ciriolo, M. R. (2018) · Oncogene · doi:10.1038/s41388-018-0545-0 · Cited by 60
Navarro, A. M., Pronk, R., van der Geest, A. T., Oliynyk, G., Nordgren, A., Arsenian‐Henriksson, M., Falk, A., & Wilhelm, M. (2020) · Cell Death and Disease · doi:10.1038/s41419-019-2208-7 · Cited by 60
Serpe, L., Canaparo, R., Varchi, G., Ballestri, M., Foglietta, F., Sotgiu, G., Guerrini, A., Francovich, A., Civera, P., & Frairia, R. (2013) · International Journal of Nanomedicine · doi:10.2147/ijn.s51070 · Cited by 54
Ward, N. P., Kang, Y. P., Falzone, A., Boyle, T. A., & DeNicola, G. M. (2020) · The Journal of Experimental Medicine · doi:10.1084/jem.20191689 · Cited by 56
“Loss of p53 function is known to promote glycolytic flux at the expense of mitochondrial metabolism (Zhang et al., 2013; Puzio-Kuter, 2011).”
BackgroundMetabolic Responses of Primary and Transformed Cells to Intracellular Listeria monocytogenes
Gillmaier, N., Götz, A., Schulz, A., Eisenreich, W., & Goebel, W. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052378 · Cited by 59
“The metabolism of mammalian cells is under the control of a complex regulatory network consisting of several signalling pathways that converge in the activation of several transcription factors, such as p53 [22,23], Myc [24,25] and HIF-1 [25,26].”
Histone Deacetylase Inhibitor-Induced Autophagy in Tumor Cells: Implications for p53
Mrakovcic, M., Kleinheinz, J., & Fröhlich, L. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18091883 · Cited by 51
“Thus, for example, signals resulting from DNA damage, oncogene activation, hypoxia, and oxidative stress can activate p53 [150].”
BackgroundP53 activation plays a crucial role in silibinin induced ROS generation via PUMA and JNK
Fan, S., Qi, M., Yu, Y., Li, L., Yao, G., Tashiro, S.-I., Onodera, S., & Ikejima, T. (2012) · Free Radical Research · doi:10.3109/10715762.2012.655244 · Cited by 52
Histone methylation in the freeze-tolerant wood frog (Rana sylvatica)
Hawkins, L. J., & Storey, K. B. (2017) · Journal of Comparative Physiology B · doi:10.1007/s00360-017-1112-7 · Cited by 58
“…interesting in the context of this study. p53 plays a part in many cellular processes such as the cell cycle (Agarwal et al. 1995), apoptosis (Lowe et al. 1993), and energy metabolism (Puzio-Kuter 2011), and thus could play a major role in the wood frog’s survival during periods of freezing.”
BackgroundNashiry, M. A., Sumi, S. S., Islam, S., Quinn, J. M. W., & Moni, M. A. (2020) · Briefings in Bioinformatics · doi:10.1093/bib/bbaa426 · Cited by 54
Montemurro, N., Perrini, P., & Rapone, B. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17228501 · Cited by 63
“p53, frequently mutated in GBM patients, promotes a variety of cellular responses to hypoxia, DNA damage and oncogene activation [25], but also regulates glycolysis and assist in maintaining mitochondrial integrity [74].”
BackgroundEpisensitization: Therapeutic Tumor Resensitization by Epigenetic Agents: A Review and Reassessment
Oronsky, B. T., Oronsky, N. C., Knox, S. J., Fanger, G. R., & Scicinski, J. J. (2014) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1871520614666140418144610 · Cited by 49
“shift the tumor cells away from glycolysis) [11, 12], may alter or reset the tumor and thereby affect the sensitivity of the tumor to a variety of subsequent or concomitant therapies.”
BackgroundGlioblastoma: Relationship between Metabolism and Immunosuppressive Microenvironment
Hernández, A., Doménech, M., Muñoz-Mármol, A. M., Carrato, C., & Balañá, C. (2021) · Cells · doi:10.3390/cells10123529 · Cited by 48
Soares, J., Raimundo, L., Pereira, N. A. L., Monteiro, Â., Gomes, S., Bessa, C., Pereira, C., Queiróz, G., Bisio, A., Fernandes, J. C., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.6775 · Cited by 63
“Actually, SLMP53-1 enhances the expression of BAX and PUMA, which besides a connection with the p53 mitochondrial pathway are also strongly involved in its pro-oxidant function [20].”
Revisiting the Warburg Effect: Diet‐Based Strategies for Cancer Prevention
Tran, Q., Lee, H., Kim, C., Kong, G., Gong, N., Kwon, S. H., Park, J., Kim, S., & Park, J. (2020) · BioMed Research International · doi:10.1155/2020/8105735 · Cited by 56
Eisenreich, W., Heesemann, J., Rudel, T., & Goebel, W. (2015) · ASM Press eBooks · doi:10.1128/9781555818883.ch3 · Cited by 47
p53-regulated autophagy is controlled by glycolysis and determines cell fate
Duan, L., Perez, R. E., Davaadelger, B., Dedkova, E. N., Blatter, L. A., & Maki, C. G. (2015) · Oncotarget · doi:10.18632/oncotarget.5218 · Cited by 51
“P53 can inhibit glycolysis and promote mitochondrial metabolism by regulating transcription of genes involved in glycolysis, mitochondrial respiration, and glutaminolysis [5-9].”
BackgroundInfluentialp53 Loss in MYC-Driven Neuroblastoma Leads to Metabolic Adaptations Supporting Radioresistance
Yogev, O., Barker, K. T., Sikka, A., de Almeida, G. S., Hallsworth, A., Smith, L., Jamin, Y., Ruddle, R. R., Koers, A., Webber, H. T., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-1939 · Cited by 52
Craveiro, M., Cretenet, G., Mongellaz, C., Matias, M. I., Caron, O., de Lima, M. C. P., Zimmermann, V. S., Solary, É., Dardalhon, V., Dulić, V., et al. (2017) · Science Signaling · doi:10.1126/scisignal.aal3024 · Cited by 52
Zamir‐Nasta, T., Razi, M., Hasanzadeh, S., & Malekinejad, H. (2017) · Environmental Toxicology · doi:10.1002/tox.22524 · Cited by 51
“The p53 controls germ cells cycle during checkpoints at the G1/S and G2/M borders.(24) Accordingly, the p53 is often upregulated after DNA damage resulting in initiation of apoptosis, stimulating repairing pathways at G1/S and/or triggering cell cycle arrest at G2/M stage.”
BackgroundMadala, H. R., Punganuru, S. R., Arutla, V., Misra, S., Thomas, T., & Srivenugopal, K. S. (2018) · Cancers · doi:10.3390/cancers10020049 · Cited by 50
“Similarly, the p53 tumor suppressor increases the expression of glutaminase 2, PUMA, TIGAR and glucose transporter 1 and 4 genes to alter the metabolism [2].”
BackgroundMosadegh, M., Hasanzadeh, S., & Razi, M. (2017) · PubMed Central · doi:10.22038/ijbms.2017.8249 · Cited by 45
Human cancer: Is it linked to dysfunctional lipid metabolism?
Hashmi, S., Wang, Y., Suman, D. S., Parhar, R. S., Collison, K. S., Conca, W., Al-Mohanna, F. A., & Gaugler, R. R. (2014) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2014.11.004 · Cited by 44
“genes [128].”
Chromosomal instability causes sensitivity to metabolic stress
Shaukat, Z., Liu, D., Choo, A., Hussain, R., O’Keefe, L. V., Richards, R. I., Saint, R. B., & Gregory, S. L. (2014) · Oncogene · doi:10.1038/onc.2014.344 · Cited by 49
Glutathione System and Oxidative Stress in Health and Disease
Bagatini, M. D. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.82965 · Cited by 52
Out of the cycle: Impact of cell cycle aberrations on cancer metabolism and metastasis
Cheung, A. H. K., Hui, C. H., Wong, K. Y., Liu, X., Chen, B., Kang, W., & To, K. F. (2022) · International Journal of Cancer · doi:10.1002/ijc.34288 · Cited by 52
Ataxia-Telangiectasia Mutated Modulation of Carbon Metabolism in Cancer
Dahl, E. S., & Aird, K. M. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00291 · Cited by 47
“Mutations in p53 lead to metabolic reprogramming in a cancer cells, allowing increased glucose intake through GLUT recruitment to the cell membrane, increased aerobic glycolysis, and decreased oxidative phosphorylation (94, 95).”
BackgroundGollapalli, K., Ghantasala, S., Kumar, S., Srivastava, R., Rapole, S., Moiyadi, A. V., Epari, S., & Srivastava, S. (2017) · Scientific Reports · doi:10.1038/s41598-017-01202-8 · Cited by 45
Yasin, M., Razi, M., & Ilkhanipour, M. (2018) · Environmental Toxicology · doi:10.1002/tox.22627 · Cited by 41
“Tumor suppressor p53, as another gene involving in intrinsic apoptosis pathway, initiates mitochondria-dependent apoptosis following severe DNA damage.(28) Accordingly, severe DNA damage triggers the p53 overexpression, which in turn is able to initiate a—apoptosis, b—DNA repairment at G1/S, and/or c—cell cycle arrest…”
BackgroundInfluentialIRES-Dependent Translational Control during Virus-Induced Endoplasmic Reticulum Stress and Apoptosis
Hanson, P., Zhang, H. M., Hemida, M. G., Ye, X., Qiu, Y., & Yang, D. (2012) · Frontiers in Microbiology · doi:10.3389/fmicb.2012.00092 · Cited by 48
“p53 is known to be upregulated during conditions of oxidative stress, which is induced by HIV infection (Kottilil et al., 2001; Puzio-Kuter, 2011).”
BackgroundBozzetti, F., & Zupec‐Kania, B. (2015) · Clinical Nutrition · doi:10.1016/j.clnu.2015.01.013 · Cited by 46
G9a Promotes Breast Cancer Recurrence through Repression of a Pro-inflammatory Program
Mabe, N. W., Garcia, N. M. G., Wolery, S. E., Newcomb, R., Meingasner, R. C., Vilona, B. A., Lupo, R., Lin, C., Chi, J., & Alvarez, J. V. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108341 · Cited by 43
“Alternatively, G9a inhibition may indirectly activate p53 through an 440 unidentified mechanism, for instance by causing replication stress, alterations to chromatin structure, or 441 metabolic stress (Avgustinova et al., 2018; Puzio-Kuter, 2011; Tanikawa et al., 2012).”
Rewriting the Epigenetic Code for Tumor Resensitization: A Review
Oronsky, B. T., Oronsky, N. C., Scicinski, J. J., Fanger, G. R., Lybeck, M., & Reid, T. R. (2014) · Translational Oncology · doi:10.1016/j.tranon.2014.08.003 · Cited by 39
“…mechanisms of resensitization — and sensitization — remain unclear, the promiscuous demethylation activity of these DNMTIs, which hit multiple targets including the tumor suppressor gene p53 that downmodulates glycolysis, may alter or reset the tumor biology and thwart chemoresistance [17 – 19].”
BackgroundInbreeding effects on gene‐specific DNA methylation among tissues of Chinook salmon
Venney, C. J., Johansson, M. L., & Heath, D. D. (2016) · Molecular Ecology · doi:10.1111/mec.13777 · Cited by 41
“We also included constitutively expressed genes in our panel of genes; these genes include transferrin (Tf) (Stafford & Belosevic 2003), heat-shock proteins (Basu et al. 2002), cellular metabolism genes such as inosine triphosphatase (itpa) (Burnstock 2012) and tumour antigen P53 (Puzio-Kuter 2011), and natural killer…”
BackgroundInfluentialTaurine and Its Anticancer Functions: In Vivo and In Vitro Study
Ma, N., He, F., Kawanokuchi, J., Wang, G., & Yamashita, T. (2022) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-93337-1_11 · Cited by 42
p53 as a double-edged sword in the progression of non-alcoholic fatty liver disease
Yan, Z., Miao, X., Zhang, B., & Xie, J. (2018) · Life Sciences · doi:10.1016/j.lfs.2018.10.051 · Cited by 40
Dietary Flavonoids in p53—Mediated Immune Dysfunctions Linking to Cancer Prevention
Siddiqui, S. S., Rahman, S., Rupasinghe, H. P. V., & Vazhappilly, C. G. (2020) · Biomedicines · doi:10.3390/biomedicines8080286 · Cited by 40
“p53 is one of the factors that reduce the utilization of glycolysis and enhance the oxidative phosphorylation of cancer cells [23].”
BackgroundAhuja, S., & Zaheer, S. (2025) · Immunology · doi:10.1111/imm.70045 · Cited by 55
“Wild-type (WT) p53 favours oxidative metabolism by inducing SCO2 to promote ETC activity and TIGAR to inhibit glycolysis via suppression of PFK1 [141–143].”
Tumor Suppression by p53: Fall of the Triumvirate?
Hock, A. K., & Vousden, K. H. (2012) · Cell · doi:10.1016/j.cell.2012.05.024 · Cited by 41
Allende-Vega, N., Krzywińska, E., Orecchioni, S., López-Royuela, N., Reggiani, F., Talarico, G., Rossi, J., Rossignol, R., Hicheri, Y., Cartron, G., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.4653 · Cited by 46
“It Oncotarget19229www.impactjournals.com/oncotarget promotes OXPHOS and inhibits glycolysis and thus might hinder the Warburg effect in many cancers [17]. p53 stimulates metabolism by inducing the expression of different metabolic genes, such as cytochrome c oxidase 2 (SCO2), glutaminase 2 (GLS2), p53 up-regulated mod…”
BackgroundThe Tumor Suppressor, P53, Decreases the Metal Transporter, ZIP14
Zhao, N., Zhang, A., Wortham, A. M., Jue, S. F., Knutson, M. D., & Enns, C. A. (2017) · Nutrients · doi:10.3390/nu9121335 · Cited by 40
Cell Intrinsic and Systemic Metabolism in Tumor Immunity and Immunotherapy
Coleman, M. F., Cozzo, A. J., Pfeil, A. J., Etigunta, S. K., & Hursting, S. D. (2020) · Cancers · doi:10.3390/cancers12040852 · Cited by 39
“while promoting glutamine metabolism [51].”
Uddin, M. A., & Barabutis, N. (2020) · DNA repair · doi:10.1016/j.dnarep.2020.102952 · Cited by 38
“P53 is a tumor suppressor protein involved in several aspects of human function, partially due to the regulation of glycolysis and oxidative phosphorylation [1].”
BackgroundChanges in metabolism affect expression of ABC transporters through ERK5 and depending on p53 status
Belkahla, S., Khan, A. U. H., Gitenay, D., Alexia, C., Gondeau, C., Vo, D.-N., Orecchioni, S., Talarico, G., Bertolini, F., Cartron, G., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.23305 · Cited by 38
“It induces the expression of different metabolic genes, such as cytochrome c oxidase 2 (SCO2), glutaminase 2 (GLS2), p53 up-regulated modulator of apoptosis (PUMA), glucose transporter 1 and 4 (GLUT1 and GLUT4) and TP53induced glycolysis and apoptosis regulator (TIGAR) [6, 7].”
BackgroundMondal, P., Gadad, S. S., Adhikari, S., Ramos, E., Sen, S., Prasad, P., & Das, C. (2021) · The FASEB Journal · doi:10.1096/fj.202002486rr · Cited by 37
The metabolism of cells regulates their sensitivity to NK cells depending on p53 status
Belkahla, S., Marco-Brualla, J., de Maudave, A. F., Falvo, P., Allende-Vega, N., Constantinides, M., Khan, A. U. H., Coënon, L., Alexia, C., Mitola, G., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-07281-6 · Cited by 35
Selenium Suppresses Leukemia through the Action of Endogenous Eicosanoids
Gandhi, U. H., Kaushal, N., Hegde, S., Finch, E. R., Kudva, A. K., Kennett, M. J., Jordan, C. T., Paulson, R. F., & Prabhu, K. S. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-3694 · Cited by 39
Kumar, A., Corey, C. G., Scott, I., Shiva, S., & D’Cunha, J. (2016) · PLoS ONE · doi:10.1371/journal.pone.0160783 · Cited by 35
“P53 also plays a key role in mitochondrial energy metabolism by regulating metabolic events [40].”
BackgroundThe role of hypernitrosylation in the pathogenesis and pathophysiology of neuroprogressive diseases
Morris, G., Walder, K. R., Carvalho, A. F., Tye, S. J., Lucas, K., Berk, M., & Maes, M. H. J. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.07.017 · Cited by 33
“However, p53 family proteins also exert a number of other functions in cells including stimulating oxidative phosphorylation while inhibiting glycolysis and influencing lipid metabolism, glutamine metabolism, antioxidant defences and the cellular redox balance (Kruiswijk et al., 2015; Liang et al., 2013; Puzio-Kuter,…”
Ponnusamy, L., & Manoharan, R. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2021.118975 · Cited by 35
Functional Genomics of the Pediatric Obese Asthma Phenotype Reveal Enrichment of Rho-GTPase Pathways
Rastogi, D., Johnston, A. D., Nico, J., Loh, L. N., Jorge, Y., Suzuki, M., Macián, F., & Greally, J. M. (2020) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201906-1199oc · Cited by 37
“Intriguingly, the mTORC1 pathway is also activated by insulin (44) that increases GLUT1 and GLUT4 translocation to the cell surface in the setting of Th-cell activation (45), which is dependent on increased T-cell metabolism (45).”
BackgroundMetabolic Anti-Cancer Effects of Melatonin: Clinically Relevant Prospects
Samec, M., Líšková, A., Koklesová, L., Zhai, K., Varghese, E., Samuel, S. M., Šudomová, M., Lučanský, V., Kassayová, M., Péč, M. J., et al. (2021) · Cancers · doi:10.3390/cancers13123018 · Cited by 41
Chemical Metabolic Inhibitors for the Treatment of Blood-Borne Cancers
Villalba, M., López-Royuela, N., Krzywińska, E., Rathore, M. G., Hipskind, R. A., Haouas, H., & Allende-Vega, N. (2014) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/18715206113136660374 · Cited by 35
“aerobic glycolysis by activating the expression of hexokinase-2 (HK2)[64].”
BackgroundChen, L., Ahmad, N., & Liu, X. (2016) · Cell Cycle · doi:10.1080/15384101.2016.1151582 · Cited by 35
“Recently, p53 has also been shown to regulate several energy metabolism pathways, including both glycolysis and mitochondrial respiration.(11,12) To support, activation of p53 suppresses glycolysis through directly or indirectly inhibiting the transcription of several factors that are important in the glycolytic pathw…”
Background
Metadata
- Authors
- Puzio-Kuter, A. M.
- Venue
- Genes & Cancer
- Publisher
- SAGE Publications
- Published
- 2011-04-01
- Volume
- 2
- Issue
- 4
- Pages
- 385-391
- ISSN
- 1947-6019 (ISSN-L)
- 1947-6027
- PMC
- PMC3135642
- OpenAlex
- W2147294934
- Cited by
- 273
- References
- 60
- Citations by year
- 2026: 9 · 2025: 11 · 2024: 20 · 2023: 13 · 2022: 23 · 2021: 21 · 2020: 26 · 2019: 21 · 2018: 21 · 2017: 24 · 2016: 17 · 2015: 18 · 2014: 24 · 2013: 9 · 2012: 14
- FWCI
- 5.33
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Genes & Cancer (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- p53, tumor suppressor, cancer metabolism, aerobic glycolysis, oxidative phosphorylation, metabolic reprogramming, energy metabolism, oxidative stress, DNA damage response, hypoxia, oncogenes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.